...
首页> 外文期刊>Applied biochemistry and biotechnology, Part A. enzyme engineering and biotechnology >Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase
【24h】

Bovine Lactoferrampin, Human Lactoferricin, and Lactoferrin 1-11 Inhibit Nuclear Translocation of HIV Integrase

机译:牛乳铁蛋白,人乳铁蛋白和乳铁蛋白1-11抑制HIV整合酶的核易位

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study aimed to investigate fragments derived from human and bovine lactoferrins for ability to inhibit nuclear translocation of HIV-1 integrase. It was shown that human lactoferricin, human lactoferrin 1-11, and bovine lactoferrampin reduced nuclear distribution of HIV-1 integrase. Bovine lactoferrampin could inhibit both the activity and nuclear translocation of HIV-1 integrase. Human lactoferrampin, bovine lactoferricin, and bovine lactoferrin 1-11 had no effect on HIV-1 integrase nuclear translocation. Human lactoferrampin which inhibited the activity of integrase did not prevent its nuclear translocation. Human lactoferricin and lactoferrin 1-11 did not inhibit HIV-1 integrase nuclear translocation despite their ability to attenuate the enzyme activity. The discrepancy between the findings on reduction of HIV-1 activity and inhibition of nuclear translocation of HIV-1 integrase was due to the different mechanisms involved. A similar reasoning can also be applied to the different inhibitory potencies of the milk peptides on different HIV enzymes, i.e., nuclear translocation.
机译:这项研究旨在调查人类和牛乳铁蛋白的片段具有抑制HIV-1整合酶核易位的能力。结果表明,人乳铁蛋白,人乳铁蛋白1-11和牛乳铁蛋白降低了HIV-1整合酶的核分布。牛乳铁蛋白可同时抑制HIV-1整合酶的活性和核易位。人乳铁蛋白,牛乳铁蛋白和牛乳铁蛋白1-11对HIV-1整合酶核易位没有影响。抑制整合酶活性的人乳铁蛋白没有阻止其核转运。尽管人乳铁蛋白和乳铁蛋白1-11具有减弱酶活性的能力,但它们不抑制HIV-1整合酶的核易位。关于减少HIV-1活性和抑制HIV-1整合酶核转位的发现之间的差异是由于所涉及的机制不同。类似的推理也可以应用于乳肽对不同HIV酶的不同抑制能力,即核易位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号